Pulse Journal Club Trending Explore Questions Researchers

Download the App

Join discussions, follow papers, and never miss your next session.

© Synapse Social LLC, 2026Privacy Policy

Home Explore Journal Club Trending

⌘+K

nCounter® PanCancer Immune Profiling Panel (NanoString Technologies, Inc., Seattle, WA) | Synapse

August 27, 2015Open Access

nCounter® PanCancer Immune Profiling Panel (NanoString Technologies, Inc., Seattle, WA)

Key Points

Key points are not available for this paper at this time.

Abstract

The nCounter PanCancer Immune Profiling Panel is a unique 770-plex gene expression panel to measure the human immune response in both solid and liquid cancer types. The panel measures many features of the immune response to facilitate rapid development of clinical actionable gene expression profiles

Mark Helpful

Bookmark

Relay

View Full Paper

Mark Helpful

Bookmark

Relay

View Full Paper

Cite This Study

Alessandra Cesano (Thu,) studied this question.

synapsesocial.com/papers/69e42c6a8de97b87b7a46e8b https://doi.org/https://doi.org/10.1186/s40425-015-0088-7

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-42015 · 447 citations
2Direct multiplexed measurement of gene expression with color-coded probe pairs2008 · 2,121 citations
3A Gene-Expression Signature as a Predictor of Survival in Breast Cancer2002 · 6,519 citations
4Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens2014 · 308 citations
5Performance comparison of one-color and two-color platforms within the Microarray Quality Control (MAQC) project2006 · 515 citations